Literature DB >> 31949716

Glucocorticoids inhibit production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.

Yun Chen1, Min Zhang2, Yijie Zheng3.   

Abstract

Glucocorticoids are anti-inflammatory agents that are widely used in clinical practice. Increasing evidence has identified exosomes as important mediators in inflammation, but it is unknown whether glucocorticoids regulate exosome secretion and function. In the present study, we observed a reduction of exosome secretion in lipopolysaccharide (LPS)-induced RAW264.7 macrophages following treatment with dexamethasone. Importantly, exosomes isolated from LPS-induced RAW264.7 macrophages increased TNF-α and IL-6 production in RAW264.7 cells. However, this increase was less pronounced following treatment with exosomes isolated from dexamethasone-treated cells. Moreover, dexamethasone decreased expression of pro-inflammatory microRNA-155 in exosomes from LPS-induced RAW264.7 macrophages. We postulate that exosomes are novel targets in the anti-inflammatory effect of glucocorticoids in LPS-induced macrophage inflammatory responses. These findings will benefit the development of new approaches for anti-inflammatory therapeutics. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Exosome; glucocorticoid; inflammation; microRNA-155

Year:  2018        PMID: 31949716      PMCID: PMC6962844     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  37 in total

Review 1.  Exosomes for cancer immunotherapy.

Authors:  F Andre; B Escudier; E Angevin; T Tursz; L Zitvogel
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

Review 2.  Glucocorticoids for human skin: new aspects of the mechanism of action.

Authors:  M Schafer-Korting; B Kleuser; M Ahmed; H-D Holtje; H C Korting
Journal:  Skin Pharmacol Physiol       Date:  2005 May-Jun       Impact factor: 3.479

Review 3.  The dexamethasone drug delivery system: indications and evidence.

Authors:  Nikolas J S London; Allen Chiang; Julia A Haller
Journal:  Adv Ther       Date:  2011-03-12       Impact factor: 3.845

4.  Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro.

Authors:  Ali Danesh; Heather C Inglis; Rachael P Jackman; Shiquan Wu; Xutao Deng; Marcus O Muench; John W Heitman; Philip J Norris
Journal:  Blood       Date:  2013-12-12       Impact factor: 22.113

5.  Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Authors:  Xiaodong Chen; Sirui Chen; Chunlin Li; Yankun Zhu; Bing Peng
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

Review 6.  Exosomes as a novel way of interneuronal communication.

Authors:  Mathilde Chivet; Charlotte Javalet; Fiona Hemming; Karin Pernet-Gallay; Karine Laulagnier; Sandrine Fraboulet; Rémy Sadoul
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

7.  Glucocorticoids.

Authors:  Peter J Barnes
Journal:  Chem Immunol Allergy       Date:  2014-05-22

8.  Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase.

Authors:  Tsuyoshi Shuto; Akira Imasato; Hirofumi Jono; Akihiro Sakai; Haidong Xu; Takahiro Watanabe; Davida D Rixter; Hirofumi Kai; Ali Andalibi; Fred Linthicum; Yue-Ling Guan; Jiahuai Han; Andrew C B Cato; David J Lim; Shizuo Akira; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

9.  Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory.

Authors:  Sanchita Bhatnagar; Jeffrey S Schorey
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

Review 10.  Exosomes as mediators of neuroinflammation.

Authors:  Archana Gupta; Lynn Pulliam
Journal:  J Neuroinflammation       Date:  2014-04-03       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.